{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:25:18Z","timestamp":1791595518834,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science Fund of Jiangxi Provincial Health Commission","award":["202410643"],"award-info":[{"award-number":["202410643"]}]},{"name":"the Science Fund of Jiangxi Provincial Health Commission","award":["202410643"],"award-info":[{"award-number":["202410643"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"DOI":"10.1007\/s40520-025-03193-3","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:26:02Z","timestamp":1759847162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Synergistic effects of diabetes and sarcopenic obesity on cardiovascular disease risk in middle-aged and elderly Chinese adults: a large-scale prospective cohort study"],"prefix":"10.1007","volume":"37","author":[{"given":"Fang","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"25","key":"3193_CR1","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","volume":"80","author":"M Lindstrom","year":"2022","unstructured":"Lindstrom M, DeCleene N, Dorsey H et al (2022) Global burden of cardiovascular diseases and risks collaboration, 1990\u20132021. J Am Coll Cardiol 80(25):2372\u20132425. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.001","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"3193_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/CIRCULATIONAHA.123.065717","volume":"149","author":"AO Mocumbi","year":"2024","unstructured":"Mocumbi AO (2024) Cardiovascular health care in Low- and Middle-Income countries. Circulation 149(8):557\u2013559. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.065717","journal-title":"Circulation"},{"issue":"12","key":"3193_CR3","doi-asserted-by":"publisher","first-page":"e1041","DOI":"10.1016\/S2468-2667(22)00170-0","volume":"7","author":"X Zhang","year":"2022","unstructured":"Zhang X, Lu J, Yang Y et al (2022) Cardiovascular disease prevention and mortality across 1 million urban populations in china: data from a nationwide population-based study. Lancet Public Health 7(12):e1041\u2013e1050. https:\/\/doi.org\/10.1016\/S2468-2667(22)00170-0","journal-title":"Lancet Public Health"},{"issue":"1","key":"3193_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40779-025-00615-1","volume":"12","author":"YC Zhou","year":"2025","unstructured":"Zhou YC, Liu JM, Zhao ZP et al (2025) The National and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050. Mil Med Res 12(1):28. https:\/\/doi.org\/10.1186\/s40779-025-00615-1","journal-title":"Mil Med Res"},{"key":"3193_CR5","doi-asserted-by":"publisher","unstructured":"Wong ND Sattar N (2023) Cardiovascular risk in diabetes mellitus: epidemiology, assessment, and prevention. Nat Reviews Cardiol 20(10):685\u2013695. https:\/\/doi.org\/10.1038\/s41569-023-00877-z","DOI":"10.1038\/s41569-023-00877-z"},{"issue":"10","key":"3193_CR6","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.2337\/dc23-0952","volume":"46","author":"C Ke","year":"2023","unstructured":"Ke C, Lipscombe LL, Weisman A et al (2023) Change in the relation between age and cardiovascular events among men and women with diabetes compared with those without diabetes in 1994\u20131999 and 2014\u20132019: A Population-Based cohort study. Diabetes Care 46(10):e200\u2013e202. https:\/\/doi.org\/10.2337\/dc23-0952","journal-title":"Diabetes Care"},{"issue":"19","key":"3193_CR7","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287(19):2570\u20132581. https:\/\/doi.org\/10.1001\/jama.287.19.2570","journal-title":"JAMA"},{"issue":"10","key":"3193_CR8","doi-asserted-by":"publisher","first-page":"afac220","DOI":"10.1093\/ageing\/afac220","volume":"51","author":"AA Sayer","year":"2022","unstructured":"Sayer AA, Cruz-Jentoft A (2022) Sarcopenia definition, diagnosis, and treatment: consensus is growing. Age Ageing 51(10):afac220. https:\/\/doi.org\/10.1093\/ageing\/afac220","journal-title":"Age Ageing"},{"key":"3193_CR9","doi-asserted-by":"publisher","unstructured":"Batsis JA, Villareal DT (2018) Sarcopenic obesity in older adults: aetiology, epidemiology, and treatment strategies. Nat Reviews Endocrinol 14(9):513\u2013537. https:\/\/doi.org\/10.1038\/s41574-018-0062-9","DOI":"10.1038\/s41574-018-0062-9"},{"issue":"5","key":"3193_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","volume":"20","author":"CM Prado","year":"2024","unstructured":"Prado CM, Batsis JA, Donini LM et al (2024) Sarcopenic obesity in older adults: A clinical overview. Nat Reviews Endocrinol 20(5):261\u2013277. https:\/\/doi.org\/10.1038\/s41574-023-00943-z","journal-title":"Nat Reviews Endocrinol"},{"key":"3193_CR11","doi-asserted-by":"publisher","first-page":"1185221","DOI":"10.3389\/fendo.2023.1185221","volume":"14","author":"S Wei","year":"2023","unstructured":"Wei S, Nguyen TT, Zhang Y et al (2023) Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol 14:1185221. https:\/\/doi.org\/10.3389\/fendo.2023.1185221","journal-title":"Front Endocrinol"},{"key":"3193_CR12","doi-asserted-by":"publisher","unstructured":"Chuan F, Chen S, Ye X et al (2022) Sarcopenic obesity predicts negative health outcomes among older patients with type 2 diabetes: the ageing and body composition of diabetes (ABCD) cohort study. Clin Nutr 41(12):2740\u20132748. https:\/\/doi.org\/10.1016\/j.clnu.2022.10.023","DOI":"10.1016\/j.clnu.2022.10.023"},{"key":"3193_CR13","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/DMSO.S186600","volume":"12","author":"J Mesinovic","year":"2019","unstructured":"Mesinovic J, Zengin A, De Courten B et al (2019) Sarcopenia and type 2 diabetes mellitus: A bidirectional relationship. Diabetes Metab Syndr Obes 12:1057\u20131072. https:\/\/doi.org\/10.2147\/DMSO.S186600","journal-title":"Diabetes Metab Syndr Obes"},{"key":"3193_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.arr.2016.09.008","volume":"35","author":"A Kalinkovich","year":"2017","unstructured":"Kalinkovich A, Livshits G (2017) Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev 35:200\u2013221. https:\/\/doi.org\/10.1016\/j.arr.2016.09.008","journal-title":"Ageing Res Rev"},{"issue":"1","key":"3193_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP et al (2014) Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol 43(1):61\u201368. https:\/\/doi.org\/10.1093\/ije\/dys203","journal-title":"Int J Epidemiol"},{"issue":"11","key":"3193_CR16","doi-asserted-by":"publisher","first-page":"18711877","DOI":"10.1093\/aje\/kwz170","volume":"188","author":"X Chen","year":"2019","unstructured":"Chen X, Crimmins E, Hu PP et al (2019) Venous Blood-Based biomarkers in the China health and retirement longitudinal study: rationale, design, and results from the 2015 wave. Am J Epidemiol 188(11):18711877. https:\/\/doi.org\/10.1093\/aje\/kwz170","journal-title":"Am J Epidemiol"},{"issue":"Suppl 1","key":"3193_CR17","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association (2021) Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 44(Suppl 1):S15\u2013S33. https:\/\/doi.org\/10.2337\/dc21-S002","journal-title":"Diabetes Care"},{"issue":"3","key":"3193_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000521241","volume":"15","author":"LM Donini","year":"2022","unstructured":"Donini LM, Busetto L, Bischoff SC et al (2022) Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts 15(3):321\u2013335. https:\/\/doi.org\/10.1159\/000521241","journal-title":"Obes Facts"},{"issue":"1","key":"3193_CR19","first-page":"1","volume":"40","author":"Chinese Medical Association(","year":"2024","unstructured":"Chinese Medical Association (2024) Chinese guidelines for the prevention and treatment of obesity (2024 edition). Chin J Endocrinol Metabolism 40(1):1\u201328","journal-title":"Chin J Endocrinol Metabolism"},{"issue":"3","key":"3193_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21(3):300\u2013307e2. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"3193_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12916-023-03172-3","volume":"21","author":"J Johansson","year":"2023","unstructured":"Johansson J, Grimsgaard S, Strand BH et al (2023) Comparing associations of handgrip strength and chair stand performance with all-cause mortality-implications for defining probable sarcopenia: the Troms\u00f8 study 2015\u20132020. BMC Med 21(1):451. https:\/\/doi.org\/10.1186\/s12916-023-03172-3","journal-title":"BMC Med"},{"key":"3193_CR22","doi-asserted-by":"publisher","unstructured":"Dent E, Morley JE, Cruz-Jentoft AJ et al (2018) International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging 22(10):1148\u20131161https:\/\/doi.org\/10.1007\/s12603-018-1139-9","DOI":"10.1007\/s12603-018-1139-9"},{"key":"3193_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ahj.2019.08.008","volume":"217","author":"AG Brellenthin","year":"2019","unstructured":"Brellenthin AG, Lanningham-Foster LM, Kohut ML et al (2019) Comparison of the cardiovascular benefits of resistance, aerobic, and combined exercise (CardioRACE): rationale, design, and methods. Am Heart J 217:101\u2013111. https:\/\/doi.org\/10.1016\/j.ahj.2019.08.008","journal-title":"Am Heart J"},{"key":"3193_CR24","doi-asserted-by":"publisher","unstructured":"Nunes EA, Colenso-Semple L, McKellar SR et al (2022) Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults. J Cachexia Sarcopenia Muscle 13(2):795\u2013810. https:\/\/doi.org\/10.1002\/jcsm.1292","DOI":"10.1002\/jcsm.1292"},{"key":"3193_CR25","doi-asserted-by":"publisher","unstructured":"Jing T, Zhang S, Bai M et al (2023) Effect of dietary approaches on glycemic control in patients with type 2 diabetes: A systematic review with network Meta-Analysis of randomized trials. Nutrients 15(14):3156. https:\/\/doi.org\/10.3390\/nu15143156","DOI":"10.3390\/nu15143156"},{"issue":"Suppl 2","key":"3193_CR26","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.2337\/dc09-S302","volume":"32","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA, Tripathy D (2009) Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32(Suppl 2):S157\u2013S163. https:\/\/doi.org\/10.2337\/dc09-S302","journal-title":"Diabetes Care"},{"key":"3193_CR27","doi-asserted-by":"publisher","first-page":"1187735","DOI":"10.3389\/fcvm.2023.1187735","volume":"10","author":"A Cesaro","year":"2023","unstructured":"Cesaro A, De Michele G, Fimiani F et al (2023) Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options. Front Cardiovasc Med 10:1187735. https:\/\/doi.org\/10.3389\/fcvm.2023.1187735","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"3193_CR28","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1210\/jc.2017-01922","volume":"102","author":"EJ Barrett","year":"2017","unstructured":"Barrett EJ, Liu Z, Khamaisi M et al (2017) Diabetic microvascular disease: an endocrine society scientific statement. J Clin Endocrinol Metab 102(12):4343\u20134410. https:\/\/doi.org\/10.1210\/jc.2017-01922","journal-title":"J Clin Endocrinol Metab"},{"key":"3193_CR29","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3389\/fendo.2020.00568","volume":"11","author":"M Wang","year":"2020","unstructured":"Wang M, Tan Y, Shi Y et al (2020) Diabetes and sarcopenic obesity:pathogenesis, diagnosis, and treatments. Front Endocrinol 11:568. https:\/\/doi.org\/10.3389\/fendo.2020.00568","journal-title":"Front Endocrinol"},{"issue":"14","key":"3193_CR30","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1093\/eurjpc\/zwad392","volume":"31","author":"V Artola Arita","year":"2024","unstructured":"Artola Arita V, Beigrezaei S, Franco OH (2024) Risk factors for cardiovascular disease: the known unknown. Eur J Prev Cardiol 31(14):e106\u2013e107. https:\/\/doi.org\/10.1093\/eurjpc\/zwad392","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"3193_CR31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/jcsm.13221","volume":"14","author":"X Zuo","year":"2023","unstructured":"Zuo X, Li X, Tang K et al (2023) Sarcopenia and cardiovascular diseases: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 14(3):1183\u20131198. https:\/\/doi.org\/10.1002\/jcsm.13221","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3193_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pcad.2022.11.013","volume":"78","author":"AW Tutor","year":"2023","unstructured":"Tutor AW, Lavie CJ, Kachur S et al (2023) Updates on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis 78:2\u201310. https:\/\/doi.org\/10.1016\/j.pcad.2022.11.013","journal-title":"Prog Cardiovasc Dis"},{"key":"3193_CR33","doi-asserted-by":"publisher","unstructured":"Kim JH, Cho JJ, Park YS (2015) Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci 30(3):264\u2013271. https:\/\/doi.org\/10.3346\/jkms.2015.30.3.264","DOI":"10.3346\/jkms.2015.30.3.264"},{"issue":"1","key":"3193_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jcsm.13397","volume":"15","author":"D Kim","year":"2024","unstructured":"Kim D, Lee J, Park R et al (2024) Association of low muscle mass and obesity with increased all-cause and cardiovascular disease mortality in US adults. J Cachexia Sarcopenia Muscle 15(1):240\u2013254. https:\/\/doi.org\/10.1002\/jcsm.13397","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"Suppl 1","key":"3193_CR35","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/dc23-S006","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR et al (2023) Glycemic targets: standards of care in diabetes. Diabetes Care 46(Suppl 1):S97\u2013S110. https:\/\/doi.org\/10.2337\/dc23-S006","journal-title":"Diabetes Care"},{"issue":"1","key":"3193_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-025-03193-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-025-03193-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-025-03193-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:26:03Z","timestamp":1759847163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-025-03193-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3193"],"URL":"https:\/\/doi.org\/10.1007\/s40520-025-03193-3","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical Review Committee of Peking University approved the human studies, which adhered to local laws and institutional guidelines. Participants gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}